Paul Herrling - Evotec AG Insider

Evotec AG -- USA Stock  

USD 26.47  0.00  0.00%

Member of the Supervisory Board

Prof
Age: 63  Executive Since 2014  Ph.D    
49 4056 0810  http://www.evotec.com
Paul Linus Herrling, Ph.D., was Member of the Supervisory Board at Evotec AG from June 17, 2014 till 2017. He was Member of the Remuneration and Nomination Committee at the Company. He is former head of global research of Novartis Pharma AG. He is Chairman of the Board at Novartis Institute for Tropical Disease Ltd. Member of Board of Novarits Institute for Functional Genomics La Jolla and Novarits International Pharmaceuticals, Hamilton. He is also Vice President of Eidgenossische Technische Hochschule.

Management Efficiency

The company has return on total asset (ROA) of 5.91 % which means that it generated profit of $5.91 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.68 % meaning that it generated $13.68 on every $100 dollars invested by stockholders.
The company has accumulated 9.53 M in total debt with debt to equity ratio (D/E) of 2.5 implying the company greatly relies on financing operations through barroing. Evotec AG has Current Ratio of 4.88 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Evotec AG offer drug discovery solutions to the pharmaceutical, biotechnology, and academic sectors worldwide. Evotec AG (EVOTF) is traded on OTC Market in USA. It is located in Hamburg, and employs 1,000 people.

Did you try this?

Run Idea Breakdown Now
   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaixs investment ideas are predefined, sector-focused investing themes
Hide  View All  Next  Launch Idea Breakdown
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Evotec AG to your portfolio

Top Management

Evotec AG Leadership Team
Werner Lanthaler, CEO
Claus Braestrup, Executive
Michael Shalmi, Executive, MBA
Mario Polywka, COO, Ph.D
Mary Tanner, Executive
Roland Oetker, Chairman
Andreas Pinkwart, Executive
Paul Herrling, Executive, Ph.D
Colin Bond, CFO, MBA
Cord Dohrmann, Executive
Iris LoewFriedrich, Executive, Ph.D
Bernd Hirsch, Executive
Enno Spillner, CFO
Elaine Sullivan, Executive
Wolfgang Plischke, Chairman, Ph.D

Stock Performance

Evotec AG Performance Indicators